Literature DB >> 8259428

Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy.

N Honda1, Q Guo, H Uchida, H Ohishi, Y Hiasa.   

Abstract

PURPOSE: To evaluate the usefulness of percutaneous hot saline injection therapy (PSIT) in the treatment of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Twenty patients with HCC (23 nodules) underwent PSIT. Mean tumor diameter was < or = 30 mm. PSIT was performed by injecting hot saline into the HCC. The therapeutic effect of PSIT was evaluated with computed tomography, angiography, measurement of alpha-fetoprotein levels, and histopathologic examination of needle biopsy and resected specimens.
RESULTS: No complications were encountered, and a therapeutic effect was obtained in all cases. When the injected material cools, it becomes physiologic saline making it possible to inject relatively large volumes in a single session.
CONCLUSION: PSIT has promise as a form of curative local therapy for small HCCs and is expected to exert a safe and favorable therapeutic effect on large HCCs as well.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259428     DOI: 10.1148/radiology.190.1.8259428

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  [Diagnosis and therapy of hepatocellular carcinoma].

Authors:  H Reinwald
Journal:  Med Klin (Munich)       Date:  1997-11-15

2.  Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma.

Authors:  Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki; Naoki Hosomi; Yoshiaki Miyauchi; Takashi Himoto; Yasuhiko Kimura; Seiji Nakai; Akihiro Deguchi; Hirohito Yoneyama; Shuhei Yoshida; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

3.  Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver.

Authors:  Asahiro Morishita; Teppei Sakamoto; Hideki Kobara; Tomoko Tadokoro; Kyoko Ohura; Koji Fujita; Joji Tani; Hisaaki Miyoshi; Hirohito Yoneyama; Takashi Himoto; Tsutomu Masaki
Journal:  Mol Clin Oncol       Date:  2015-11-16

Review 4.  Localized hepatocellular carcinoma: therapeutic options.

Authors:  A Ribeiro; D M Nagorney; G J Gores
Journal:  Curr Gastroenterol Rep       Date:  2000-02

5.  Radiofrequency ablation for hepatocellular carcinoma and liver metastases: experience in Hospital La Paz.

Authors:  Silvia Gómez Senent; César Gómez Raposo; Noemi Manceñido Marcos; Sonia Martín Chavarri; Gemma Carrión Alonso; Antonio Olveira Martín; José María Segura Cabral; Manuel González Barón
Journal:  Clin Transl Oncol       Date:  2006-09       Impact factor: 3.405

Review 6.  Radiofrequency thermal ablation of hepatocellular carcinomas.

Authors:  H K Lim
Journal:  Korean J Radiol       Date:  2000 Oct-Dec       Impact factor: 3.500

Review 7.  Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.

Authors:  W Y Lau; Thomas W T Leung; Simon C H Yu; Stephen K W Ho
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

8.  Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver.

Authors:  Jeong Min Lee; Young Hwan Lee; Young Kon Kim; Sang Won Kim; Se Hyung Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2003-11-19       Impact factor: 5.315

9.  Sonography guided percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of cooperative training on the pretreatment assessment of the operation's feasibility.

Authors:  Min Ju Kim; Hyo K Lim; Dongil Choi; Won Jae Lee; Hyun Chul Rhim; Seonwoo Kim
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.